J. Ferlay, I. Soerjomataram, R. Dikshit, S. Eser, C. Mathers et al., Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012, Int J Cancer, vol.136, issue.5, pp.359-386, 2015.

K. Bell, D. Mar, C. Wright, G. Dickinson, J. Glasziou et al., Prevalence of incidental prostate cancer: A systematic review of autopsy studies, Int J Cancer, vol.137, issue.7, pp.1749-57, 2015.

A. M. Noone, N. Howlader, M. Krapcho, D. Miller, A. Brest et al.,

A. , L. D. Chen, H. S. Feuer, E. J. Cronin, and K. A. , SEER Cancer Statistics Review, 1975.

A. V. D'amico, R. Whittington, S. B. Malkowicz, D. Schultz, K. Blank et al.,

, Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer, JAMA, vol.280, issue.11, pp.969-74, 1998.

J. I. Epstein, L. Egevad, M. B. Amin, B. Delahunt, J. R. Srigley et al., , 2014.

, Grading of Prostatic Carcinoma: Definition of Grading Patterns and Proposal for a New Grading System, International Society of Urological Pathology (ISUP) Consensus Conference on Gleason, vol.40, pp.244-52, 2016.

T. J. Wilt, M. K. Brawer, K. M. Jones, M. J. Barry, W. J. Aronson et al., Radical prostatectomy versus observation for localized prostate cancer, N Engl J Med, vol.367, issue.3, pp.203-216, 2012.

S. Loeb, A. Berglund, and P. Stattin, Population based study of use and determinants of active surveillance and watchful waiting for low and intermediate risk prostate cancer, J Urol, vol.190, issue.5, pp.1742-1751, 2013.

S. Punnen, J. E. Cowan, J. M. Chan, P. R. Carroll, and M. R. Cooperberg, Long-term health-related quality of life after primary treatment for localized prostate cancer: results from the CaPSURE registry, Eur Urol, vol.68, issue.4, pp.600-608, 2015.

R. L. Grubb and A. S. Kibel, High-risk localized prostate cancer: role of radical prostatectomy, Curr Opin Urol, vol.20, issue.3, pp.204-214, 2010.

A. Bill-axelson, L. Holmberg, H. Garmo, J. R. Rider, K. Taari et al., Radical prostatectomy or watchful waiting in early prostate cancer, N Engl J Med, vol.370, issue.10, pp.932-974, 2014.

L. Salomon, F. Rozet, and M. Soulié, La chirurgie du cancer de la prostate : principes techniques et complications péri-opératoires. Progrès en Urologie, vol.25, pp.966-98, 2015.

J. Cornu, J. Terrasa, O. Cussenot, F. Haab, and B. Lukacs, Evolution of the landscape of surgical management of prostate cancer in France: the case of radical prostatectomy, Eur Urol, vol.62, issue.4, pp.735-741, 2012.

J. Walz, A. L. Burnett, A. J. Costello, J. A. Eastham, M. Graefen et al., A Critical Analysis of the Current Knowledge of Surgical Anatomy Related to Optimization of Cancer Control and Preservation of Continence and Erection in Candidates for Radical Prostatectomy, European Urology, vol.1, issue.2, pp.179-92, 2010.

J. Stolzenburg, T. Schwalenberg, L. Horn, J. Neuhaus, C. Constantinides et al.,

, Anatomical Landmarks of Radical Prostatecomy, European Urology. 1 mars, vol.51, issue.3, pp.629-668, 2007.

C. Barré, Open Radical Retropubic Prostatectomy, European Urology. 1 juill, vol.52, issue.1, pp.71-80, 2007.

T. Schlomm, H. Heinzer, T. Steuber, G. Salomon, O. Engel et al., Full Functional-Length

, Urethral Sphincter Preservation During Radical Prostatectomy, European Urology. 1 août, vol.60, issue.2, pp.320-329, 2011.

E. Haglind, S. Carlsson, J. Stranne, A. Wallerstedt, U. Wilderäng et al., Urinary Incontinence and Erectile Dysfunction After Robotic Versus Open Radical Prostatectomy: A Prospective, Controlled, Nonrandomised Trial, Eur Urol, vol.68, issue.2, pp.216-241, 2015.

C. Bastide, M. Soulié, J. Davin, and D. Rossi,

, Prog Urol. avr, vol.17, issue.2, pp.182-190, 2007.

L. Cormier, C. Bastide, P. Beuzeboc, G. Fromont, C. Hennequin et al., Prostate cancer surgical margin: review by the CCAFU (Oncology Committee of the French Association of

, Urology)

, Prog Urol. mai, vol.24, issue.6, pp.334-379, 2014.

L. Egevad, J. R. Srigley, and B. Delahunt, International society of urological pathology consensus conference on handling and staging of radical prostatectomy specimens, Adv Anat Pathol. juill, vol.18, issue.4, pp.301-306, 2011.

H. Samaratunga, R. Montironi, L. True, J. I. Epstein, D. F. Griffiths et al.,

, Working group 1: specimen handling, International Society of Urological Pathology (ISUP) Consensus Conference on Handling and Staging of Radical Prostatectomy Specimens, vol.24, pp.6-15, 2011.

P. H. Tan, L. Cheng, J. R. Srigley, D. Griffiths, P. A. Humphrey et al., International Society of Urological Pathology (ISUP) Consensus Conference on Handling and Staging of Radical Prostatectomy Specimens. Working group 5: surgical margins, vol.24, pp.48-57, 2011.

M. L. Blute, D. G. Bostwick, T. M. Seay, S. K. Martin, J. M. Slezak et al., Pathologic classification of prostate carcinoma: the impact of margin status, Cancer. 1 mars, vol.82, issue.5, pp.902-910, 1998.

A. J. Stephenson, S. E. Eggener, A. V. Hernandez, E. A. Klein, M. W. Kattan et al., Do margins matter? The influence of positive surgical margins on prostate cancer-specific mortality, Eur Urol. avr, vol.65, issue.4, pp.675-80, 2014.

B. F. Chapin, J. N. Nguyen, M. F. Achim, N. Navai, S. B. Williams et al., Positive margin length and highest Gleason grade of tumor at the margin predict for biochemical recurrence after radical prostatectomy in patients with organ-confined prostate cancer, Prostate Cancer Prostatic Dis. juin, vol.21, issue.2, pp.221-228, 2018.

J. J. Oh, S. K. Hong, S. Byun, G. Choe, and S. E. Lee, Prognostic significance of positive surgical margins after radical prostatectomy among pT2 and pT3a prostate cancer, Urol Oncol. juill, vol.31, issue.5, pp.595-600, 2013.

J. E. Rosas-nava, F. Herranz-amo, E. V. Paños-fagundo, E. Lledó-garcía, and F. Verdú-tartajo,

C. Hernández-fernández, Value of positive resection margins in patients with pT2 prostate cancer

, Actas Urol Esp. mai, vol.35, issue.5, pp.272-278, 2011.

A. Damani, M. Van-hemelrijck, W. Wulaningsih, D. Crawley, and D. Cahill, Are you now a good surgeon? T2 positive margin status as a quality outcome measure following radical prostatectomy, World J Urol. janv, vol.35, issue.1, pp.35-43, 2017.

A. J. Stephenson, D. P. Wood, M. W. Kattan, E. A. Klein, P. T. Scardino et al., Extent and Number of Positive Surgical Margins Do Not Improve Accuracy of Predicting Prostate Cancer Recurrence After Radical Prostatectomy, The Journal of Urology, vol.182, issue.4, pp.1357-63, 2009.

C. P. Meyer, J. Hansen, K. Boehm, D. Tilki, F. Abdollah et al., Tumor volume improves the long-term prediction of biochemical recurrence-free survival after radical prostatectomy for localized prostate cancer with positive surgical margins, World Journal of Urology. févr, vol.35, issue.2, pp.199-206, 2017.

I. M. Thompson, C. M. Tangen, J. Paradelo, M. S. Lucia, G. Miller et al., Adjuvant radiotherapy for pathological T3N0M0 prostate cancer significantly reduces risk of metastases and improves survival: long-term followup of a randomized clinical trial, J Urol. mars, vol.181, issue.3, pp.956-62, 2009.

T. Wiegel, D. Bartkowiak, D. Bottke, C. Bronner, U. Steiner et al., Adjuvant radiotherapy versus wait-and-see after radical prostatectomy: 10-year follow-up of the ARO, p.96

/. Auo-ap, 09/95 trial, Eur Urol. août, vol.66, issue.2, pp.243-50, 2014.

M. Bolla, H. Van-poppel, B. Tombal, K. Vekemans, D. Pozzo et al., Postoperative radiotherapy after radical prostatectomy for high-risk prostate cancer: long-term results of a randomised controlled trial (EORTC trial 22911), Lancet. 8 déc, vol.380, issue.9858, pp.2018-2045, 2012.

I. M. Thompson, R. Valicenti, P. C. Albertsen, S. L. Goldenberg, C. A. Hahn et al., Adjuvant and salvage radiotherapy after prostatectomy : ASTRO/AUA guideline, vol.45, 2013.

N. Mottet, R. C. Van-den-bergh, E. Briers, L. Bourke, P. Cornford et al., European Association of Urology guidelines on prostate cancer] www.uroweb.org 36

, Recommandations en onco-urologie 2016-2018 du CCAFU : Cancer de la prostate, vol.27, pp.95-143, 2016.

S. A. Boorjian, R. J. Karnes, P. L. Crispen, R. E. Carlson, L. J. Rangel et al., The impact of positive surgical margins on mortality following radical prostatectomy during the prostate specific antigen era, J Urol. mars, vol.183, issue.3, pp.1003-1012, 2010.

M. A. Røder, F. B. Thomsen, K. D. Berg, I. Christensen, K. Brasso et al., Risk of biochemical recurrence and positive surgical margins in patients with pT2 prostate cancer undergoing radical prostatectomy, J Surg Oncol. févr, vol.109, issue.2, pp.132-140, 2014.

J. R. Caso, M. Tsivian, V. Mouraviev, T. J. Polascik, and J. W. Moul, Pathological T2 sub-divisions as a prognostic factor in the biochemical recurrence of prostate cancer, BJU Int. déc, vol.106, issue.11, pp.1623-1630, 2010.

A. Karl, A. Buchner, C. Tympner, T. Kirchner, U. Ganswindt et al., The natural course of pT2 prostate cancer with positive surgical margin: predicting biochemical recurrence, World J Urol. juill, vol.33, issue.7, pp.973-982, 2015.

D. Cao, P. A. Humphrey, F. Gao, Y. Tao, and A. S. Kibel, Ability of linear length of positive margin in radical prostatectomy specimens to predict biochemical recurrence, Urology. juin, vol.77, issue.6, pp.1409-1423, 2011.

C. Pettenati, Y. Neuzillet, C. Radulescu, J. Hervé, V. Molinié et al., Positive surgical margins after radical prostatectomy: What should we care about?, World Journal of Urology. déc, vol.33, issue.12, pp.1973-1981, 2015.

B. J. Stish, T. M. Pisansky, W. S. Harmsen, B. J. Davis, K. S. Tzou et al., Improved Metastasis-Free and Survival Outcomes With Early Salvage Radiotherapy in Men With Detectable Prostate-Specific Antigen After Prostatectomy for Prostate Cancer, JCO, vol.34, issue.32, pp.3864-71, 2016.

A. J. Stephenson, P. T. Scardino, M. W. Kattan, T. M. Pisansky, K. M. Slawin et al., Predicting the outcome of salvage radiation therapy for recurrent prostate cancer after radical prostatectomy, J Clin Oncol. 20 mai, vol.25, issue.15, pp.2035-2076, 2007.

A. Botticella, A. Guarneri, N. G. Levra, F. Munoz, A. R. Filippi et al., Biochemical and clinical outcomes after high-dose salvage radiotherapy as monotherapy for prostate cancer, J Cancer Res Clin Oncol. juill, vol.140, issue.7, pp.1111-1117, 2014.